These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24076580)

  • 1. Recent advances in the management of mantle cell lymphoma.
    Rivera-Rodriguez N; Cabanillas F
    Curr Opin Oncol; 2013 Nov; 25(6):716-21. PubMed ID: 24076580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging role of lenalidomide in the management of mantle cell lymphoma (MCL).
    Dawar R; Hernandez-Ilizaliturri F
    Best Pract Res Clin Haematol; 2012 Jun; 25(2):185-90. PubMed ID: 22687454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mantle cell lymphoma: the promise of new treatment options.
    Goy A; Kahl B
    Crit Rev Oncol Hematol; 2011 Oct; 80(1):69-86. PubMed ID: 21168343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma.
    Hess G; Keller U; Scholz CW; Witzens-Harig M; Atta J; Buske C; Kirschey S; Ruckes C; Medler C; van Oordt C; Klapper W; Theobald M; Dreyling M
    Leukemia; 2015 Aug; 29(8):1695-701. PubMed ID: 25765545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation.
    Visco C; Finotto S; Zambello R; Paolini R; Menin A; Zanotti R; Zaja F; Semenzato G; Pizzolo G; D'Amore ES; Rodeghiero F
    J Clin Oncol; 2013 Apr; 31(11):1442-9. PubMed ID: 23401442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous transplantation and management of younger patients with mantle cell lymphoma.
    Geisler CH
    Best Pract Res Clin Haematol; 2012 Jun; 25(2):211-20. PubMed ID: 22687457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mantle cell lymphoma-management in evolution.
    Rajguru S; Kahl BS
    Chin Clin Oncol; 2015 Mar; 4(1):8. PubMed ID: 25841715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
    Wang M; Fayad L; Cabanillas F; Hagemeister F; McLaughlin P; Rodriguez MA; Kwak LW; Zhou Y; Kantarjian H; Romaguera J
    Cancer; 2008 Nov; 113(10):2734-41. PubMed ID: 18973182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma.
    Robinson KS; Williams ME; van der Jagt RH; Cohen P; Herst JA; Tulpule A; Schwartzberg LS; Lemieux B; Cheson BD
    J Clin Oncol; 2008 Sep; 26(27):4473-9. PubMed ID: 18626004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mantle Cell Lymphoma: First-line Therapy in Patients Not Eligible for Stem Cell Transplantation.
    Nazeef M; Kahl BS
    Curr Treat Options Oncol; 2015 Jun; 16(6):29. PubMed ID: 25975443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide therapy induces response in relapsed mantle cell lymphoma.
    Damaj G; Lefrère F; Delarue R; Varet B; Furman R; Hermine O
    Leukemia; 2003 Sep; 17(9):1914-5. PubMed ID: 12970798
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined lenalidomide, low-dose dexamethasone, and rituximab achieves durable responses in rituximab-resistant indolent and mantle cell lymphomas.
    Ahmadi T; Chong EA; Gordon A; Aqui NA; Nasta SD; Svoboda J; Mato AR; Schuster SJ
    Cancer; 2014 Jan; 120(2):222-8. PubMed ID: 24122387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of mantle cell lymphoma: key challenges and next steps.
    Williams ME; Dreyling M; Winter J; Muneer S; Leonard JP
    Clin Lymphoma Myeloma Leuk; 2010 Oct; 10(5):336-46. PubMed ID: 21030346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of older patients with mantle-cell lymphoma.
    Kluin-Nelemans HC; Hoster E; Hermine O; Walewski J; Trneny M; Geisler CH; Stilgenbauer S; Thieblemont C; Vehling-Kaiser U; Doorduijn JK; Coiffier B; Forstpointner R; Tilly H; Kanz L; Feugier P; Szymczyk M; Hallek M; Kremers S; Lepeu G; Sanhes L; Zijlstra JM; Bouabdallah R; Lugtenburg PJ; Macro M; Pfreundschuh M; Procházka V; Di Raimondo F; Ribrag V; Uppenkamp M; André M; Klapper W; Hiddemann W; Unterhalt M; Dreyling MH
    N Engl J Med; 2012 Aug; 367(6):520-31. PubMed ID: 22873532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bortezomib, bendamustine, and rituximab in patients with relapsed or refractory follicular lymphoma: the phase II VERTICAL study.
    Fowler N; Kahl BS; Lee P; Matous JV; Cashen AF; Jacobs SA; Letzer J; Amin B; Williams ME; Smith S; Saleh A; Rosen P; Shi H; Parasuraman S; Cheson BD
    J Clin Oncol; 2011 Sep; 29(25):3389-95. PubMed ID: 21810687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the treatment of mantle cell lymphoma: a post-ASH 2009 discussion.
    Czuczman MS; Leonard JP; Williams ME
    Clin Adv Hematol Oncol; 2010 Apr; 8(4):A1-14; quiz A15. PubMed ID: 20552750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination biologic therapy without chemotherapy as initial treatment for mantle cell lymphoma: multi- center phase II study of lenalidomide plus rituximab.
    Clin Adv Hematol Oncol; 2014 Feb; 12(2 Suppl 6):17-8. PubMed ID: 24870878
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current treatment strategy in mantle cell lymphoma].
    Ogura M
    Nihon Rinsho; 2014 Mar; 72(3):499-511. PubMed ID: 24724411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.
    Ruan J; Martin P; Furman RR; Lee SM; Cheung K; Vose JM; Lacasce A; Morrison J; Elstrom R; Ely S; Chadburn A; Cesarman E; Coleman M; Leonard JP
    J Clin Oncol; 2011 Feb; 29(6):690-7. PubMed ID: 21189393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.